Warshamana-Greene, G Sakuntala <br/><br/>
The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2005 
 - 1563-71 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-1544  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carboplatin--pharmacology<br/>Carcinoma, Small Cell--drug therapy<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Enzyme-Linked Immunosorbent Assay<br/>Etoposide--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>In Situ Nick-End Labeling<br/>Insulin-Like Growth Factor I--pharmacology<br/>Lung Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>RNA, Messenger--genetics<br/>Receptor, IGF Type 1--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--genetics